Recent advances in developing synthetic carbohydrate-based vaccines for cancer immunotherapies

Area of Science:

• Oncology
• Immunology
• Carbohydrate Chemistry

Background:

• Cancer cells exhibit unique surface carbohydrate structures due to altered glycosylation.
• These aberrant carbohydrates serve as potential targets for cancer vaccines.
• Carbohydrates alone typically elicit weak immune responses, lacking T-cell dependency.

Purpose of the Study:

• To review advancements in developing carbohydrate-based anticancer vaccines.
• To summarize strategies for overcoming the poor immunogenicity of carbohydrate tumor antigens.
• To highlight novel approaches in cancer vaccine design.

Main Methods:

• Identification of tumor-associated carbohydrate antigens (e.g., GM2, Le(y), globo H, sialyl Tn, TF).
• Chemical modification of carbohydrates by linking them to immunogenic proteins or peptides.
• Review of preclinical and clinical studies on carbohydrate-based cancer vaccines.

Main Results:

• Chemically modified carbohydrates can enhance immunogenicity and induce T-cell-dependent responses.
• Various carbohydrate antigens have been explored as targets for different cancer types.
• Novel strategies are being developed to improve the efficacy of these vaccines.

Conclusions:

• Carbohydrate-based vaccines hold promise for cancer immunotherapy.
• Overcoming poor immunogenicity through conjugation is crucial for vaccine effectiveness.
• Continued research into novel approaches is essential for advancing carbohydrate-based cancer vaccines.